Skip to main content

Table 2 Treatment information, acute adverse events and response to therapy

From: High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer

Characteristic No. of patients (%)
Courses of radiotherapy  
 One course 11 (19.3)
 Two courses 46 (80.7)
Dose of radiotherapy  
 Median, Gy (range) 80 (60–86)
Radiation technology  
 3D-CRT 7 (12.3)
 IMRT 50 (87.7)
Chemotherapy regime  
 mFolfox6 2 (3.5)
 CapeOX 37 (64.9)
 Capecitabine 18 (31.6)
Cycles of chemotherapy  
 Median (range) 8 (1–11)
Grade 3–4 complications during treatment  
 Any types 18 (31.6)
 Proctitis 6 (10.5)
 Diarrhea 2 (3.5)
 Dermatitis associated with radiation 7 (12.3)
 Leukopenia 4 (7.0)
 Thrombocytopenia 6 (10.5)
Response to treatment  
 cCR 42 (73.7)
 Non-cCR 15 (26.3)
  1. 3D-CRT three-dimensional conformal radiation therapy, IMRT intensity-modulated radiation therapy, cCR clinical complete response